CASI PHARMACEUTICALS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
CASI PHARMACEUTICALS, INC. (CASIF) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $28.00 thousand as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-05-15
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $28.00K.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $25.00K.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.05M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.02M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $28.00K 20-F · filed 2026-05-15 |
| 2024-12-31 | $25.00K 20-F · filed 2025-03-31 |
| 2023-12-31 | $1.05M 20-F · filed 2024-03-28 |
| 2022-12-31 | $1.02M 20-F · filed 2023-04-26 |